Drug discovery > Pre-Clinical Development Products & Reviews

A plug and play, compact automation system for high quality proteomics sample preparation using dedicated PreOmics´ iST reagents 

Gyrolab® Generic Cyno ADA Kit Reagents enable detection of anti-drug antibodies of human IgG or Fab in cynomolgus monkey matrix.

A module for the WOLF ® G2 Cell Sorter to provide cooling and stirring of sample.

Enzyme Immunoassay for the Qualitative / Quantitative Screening of double stranded RNA in mRNA based preparations.

Immunoassay for the measurement of E.coli Host Cell Proteins

ELISA for the detection of Blinatumomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year

Enzyme Immunoassay for the Quantitative Determination of Faricimab in human serum and plasma.

Enzyme Immunoassay for the quantitative determination of Ocrelizumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Pidilizumab in serum and plasma.

Enzyme Immunoassay for the Quantitative Determination of Relatlimab in human serum and plasma

Enzyme Immunoassay for the Quantitative Determination of Teclistamab in serum and plasma

Quantitative immunoassay for Ustekinumab

Enzyme Immunoassay for the quantitative determination of Erenumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Guselkumab in serum and plasma.

Enzyme Immunoassay for the Quantitative Determination of Cemiplimab in human serum and plasma

Enzyme Immunoassay for the Quantitative Determination of Amivantamab in serum and plasma

Canakinumab (ILARIS) ELISA for quantitative determination of Canakinumab (ILARIS) in human serum

Enzyme Immunoassay for the Quantitative Determination of Teprotumumab in serum and plasma.

ELISA for the detection of Mosunetuzumab in human serum and plasma.

Enzyme Immunoassay for the Quantitative Determination of Darbepoetin in human serum and plasma

Enzyme Immunoassay for the quantitative determination of Nilotinib in serum, plasma and cell culture supernatant

Enzyme Immunoassay for the Quantitative Determination of Dasatinib in human serum and plasma

Enzyme Immunoassay for the quantitative determination of Golimumab in serum, plasma and cell culture supernatant

Enzyme Immunoassay for the quantitative determination of Necitumumab in serum and plasma.

Immunoassay for quantitative estimation of Cafilzomib in human serum and plasma.